PAULA KOSTUIK NEIDHARD: Open Payments
NPI 1518909415 · MONTGOMERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 56 payments from 25 companies in 2025. Trend: 2023 $21 · 2024 $42 · 2025 $1,206
Food & beverage: $1,082Education: $123
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $156 |
| Janssen Biotech, Inc. | 6 | $109 |
| SEAGEN INC. | 1 | $99 |
| PFIZER INC. | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Daiichi Sankyo Inc. | 5 | $84 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| Astellas Pharma US Inc | 4 | $66 |
| Celgene Corporation | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
Products named: RYBREVANT, PADCEV, PLUVICTO, Nubeqa, REBLOZYL, KEYTRUDA, Enhertu, OPDIVO.
Industry payments across OH — which companies pay providers there.
